CompaniesBoston Immune Technologies & Therapeutics
Boston Immune Technologies & Therapeutics logo

Boston Immune Technologies & Therapeutics

active
Boston, MA, United States
Founded 2014
Website
About

Immune-based Cancer Therapies, Monoclonal Antibodies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

37

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1

Recent Trials

NCT06385522Lead Sponsor
A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System
PHASE1Not yet recruiting
37 participants
Started: Aug 31, 2025 · Completed: Feb 28, 2027
Locations (1)
Headquarters
Boston, MA, United States
Map

Loading map...